Vital Care Express LogoVital Care Express
Public Health

What WHO data and a new TMS trial say about late-life depression

July 21, 2026
#mental health#older adults#depression#brain stimulation
What WHO data and a new TMS trial say about late-life depression

Key Takeaways

  • WHO estimates about 14% of adults aged 60 and older live with a mental disorder, mostly anxiety and depression, and older adults account for roughly 27% of the world’s suicide deaths.
  • A 108-person trial of accelerated theta-burst TMS for late-life depression showed nothing at week 6, then a real gap by week 12: a 52% response rate versus 33% on sham.
  • Both threads point the same way: late-life mental illness is common, badly under-treated, and the tools we have work slowly enough that patience is part of the treatment.

The scale of the problem

Mental health in old age tends to get filed under “understandable sadness,” which is exactly how it goes untreated. The WHO numbers argue against that reflex. About 14% of people aged 60 and older live with a diagnosable mental disorder, most commonly anxiety or depression, and those conditions make up roughly 10.6% of all years this age group loses to disability.

The starkest figure is suicide. Adults 60 and older account for around 27% of suicide deaths worldwide, a share far larger than the “quiet decline” framing would suggest. And the population at risk is growing fast: by 2030, one in six people on earth will be 60 or older.

What drives it

The risk factors are less about brain chemistry than about circumstance. Loneliness and social isolation sit near the top, common in later life and tightly linked to depression and anxiety. Abuse is disturbingly frequent too: WHO estimates one in six older adults experiences some form of it, physical, psychological, financial, or neglect, often at the hands of a caregiver.

Layer on bereavement, retirement, chronic physical illness, and plain ageism, and the picture is of mental illness fed by loss and exclusion. WHO’s prescription is not primarily pharmacological. It leans on community-based care: social connection programs, secure housing and income, caregiver support, and protection from abuse and age discrimination.

The TMS trial worth knowing about

Against that backdrop, a trial published in the American Journal of Psychiatry, led by Leandro da Costa Lane Valiengo at the University of Sao Paulo, tested whether a form of brain stimulation could help older adults specifically. It enrolled 108 people (average age 67) with moderate-to-severe depression, drawn from more than 1,000 screened.

The intervention was accelerated bilateral theta-burst TMS, magnetic pulses delivered to the dorsolateral prefrontal cortex, 20 daily sessions of 3,600 pulses each, then three maintenance sessions over two months.

Timepoint Result
Week 6 No significant difference vs sham
Week 12 52% clinical response (active) vs 33% (sham)
Remission No significant difference between groups
Side effects Mild headache, scalp tingling, equal in both arms

The interesting part is the timing. At week 6, active treatment and sham looked identical, which would normally read as failure. By week 12 a clear gap had opened: just over half the treated group hit a clinical response, meaning at least a 50% drop in symptoms, against a third on sham. The researchers’ read is that older brains may respond to stimulation more slowly, so the benefit accrues rather than switching on.

How much to make of it

Enough to pay attention, not enough to change practice yet. This is one randomized trial with tight entry rules, including tapering people off their antidepressants first, which is not how most older patients live. Remission rates, the harder bar, did not separate from sham. So TMS here looks like a possible add-on for late-life depression, most useful for people who have not responded to the usual options, and worth a longer look precisely because its effect shows up late.

The through-line with the WHO data is uncomfortable but useful: this is a large, under-served problem, and even the promising tools take time to work. For older adults, that argues for earlier recognition and longer follow-up, not writing off depression as just getting old.


Sources:

Disclaimer: This article is for general information only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about any medical condition or before making health decisions.

Frequently Asked Questions

How common are mental health disorders in older adults?

WHO estimates about 14% of adults aged 60 and older live with a mental disorder, most often anxiety or depression. These conditions account for roughly 10.6% of the years lived with disability in this age group, and are widely under-recognized and undertreated.

What did the theta-burst TMS trial find?

In 108 older adults (average age 67) with moderate-to-severe depression, accelerated bilateral theta-burst TMS showed no benefit over sham at week 6, but by week 12, 52% of the treated group had a clinical response (at least a 50% symptom cut) versus 33% on sham. Remission rates did not differ significantly.

Why did the benefit show up late?

The researchers suggest aging brains may adapt more slowly to the stimulation, so the effect builds over time rather than appearing right after treatment. That is a hypothesis from one trial, not a settled explanation.

Is TMS a replacement for medication or therapy?

No. This was a single randomized trial with specific entry criteria, including tapering off antidepressants. It points to TMS as a possible addition to care for older adults, not a proven substitute for existing drugs or psychosocial support.

AI Assisted